Parkinson’s disease diagnosis is currently based on a detailed neurological examination, inclusive of a review of the patient medical history and a clinical evaluation of motor and non-motor symptoms and supported by the dopamine transporter (DAT) scan, if need be [28]. Here, SLC6A3 is linked to Parkinson disease.